These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 30014319)
1. Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study. Ahmed F; Kumari S; Kondapi AK Pharm Res; 2018 Jul; 35(9):178. PubMed ID: 30014319 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy. Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy. Kumari S; Kondapi AK Int J Biol Macromol; 2017 Feb; 95():232-237. PubMed ID: 27864056 [TBL] [Abstract][Full Text] [Related]
4. MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma. Yang H; Liu Y; Qiu Y; Ding M; Zhang Y Int J Pharm; 2019 Jul; 566():585-593. PubMed ID: 31181310 [TBL] [Abstract][Full Text] [Related]
5. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies. Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764 [TBL] [Abstract][Full Text] [Related]
6. Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy. Kumar P; Lakshmi YS; Kondapi AK Pharm Res; 2017 Feb; 34(2):257-268. PubMed ID: 27928647 [TBL] [Abstract][Full Text] [Related]
7. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826 [TBL] [Abstract][Full Text] [Related]
8. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment. Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270 [TBL] [Abstract][Full Text] [Related]
9. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma. Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation. Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300 [TBL] [Abstract][Full Text] [Related]
11. Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment. Bose A; Elyagoby A; Wong TW Int J Pharm; 2014 Jul; 468(1-2):178-86. PubMed ID: 24709212 [TBL] [Abstract][Full Text] [Related]
12. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation. Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212 [TBL] [Abstract][Full Text] [Related]
13. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of lipofufol, a new triple stealth liposomal formulation of modulated 5-fu: impact on efficacy and toxicity. Fanciullino R; Mollard S; Giacometti S; Berda-Haddad Y; Chefrour M; Aubert C; Iliadis A; Ciccolini J Pharm Res; 2013 May; 30(5):1281-90. PubMed ID: 23386105 [TBL] [Abstract][Full Text] [Related]
17. Combination of Oxaliplatin and Vit.E-TPGS in Lipid Nanosystem for Enhanced Therapeutic Efficacy in Colon Cancers. Wang Y; Zhang X; Zhang W; Dong H; Zhang W; Mao J; Dai Y Pharm Res; 2018 Jan; 35(2):27. PubMed ID: 29368145 [TBL] [Abstract][Full Text] [Related]
18. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile. Kumar P; Lakshmi YS; Kondapi AK HIV Med; 2017 Aug; 18(7):452-462. PubMed ID: 28000390 [TBL] [Abstract][Full Text] [Related]
19. The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma. Yu D; Gao P; Song Y; Yang Y; Chen X; Sun Y; Li A; Wang Z Cancer Med; 2018 Mar; 7(3):600-615. PubMed ID: 29380562 [TBL] [Abstract][Full Text] [Related]
20. Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway. Granci V; Cai F; Lecumberri E; Clerc A; Dupertuis YM; Pichard C Br J Nutr; 2013 Apr; 109(7):1188-95. PubMed ID: 22874769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]